Michel J B, Dussaule J C, Choudat L, Auzan C, Nochy D, Corvol P, Menard J
Kidney Int. 1986 May;29(5):1011-20. doi: 10.1038/ki.1986.101.
In order to investigate the consequences of antihypertensive therapy on hormonal and renal parameters in one-clip, two kidney renovascular hypertension, we compared the effects of converting enzyme inhibition (CEI) with those of tripletherapy (clonidine, dihydralazine and furosemide) in this experimental model in rats. The treatment period was initiated four weeks after application of the clip and was continued for five weeks. In plasma, renin was increased and renin substrate was negatively correlated to plasma renin. Hypertension was associated with activation of the renin angiotensin system in both plasma and kidney. The degree of activation of the renin-angiotensin system in the clipped kidney and its suppression in the unclipped kidney was evaluated by two methods, renal renin content and semi-quantification of juxtaglomerular hyperplasia by immunofluorescent renin. These two methods were correlated. During the treatment period, average systolic blood pressure was 144 +/- 13 mmHg in the CEI treated group (HT1) which was not significantly different from the value found in the sham-operated group (139 +/- 4 mmHg; C2). Blood pressure, however, was lowered only to 173 +/- 18 mmHg in the group treated with tripletherapy (HT2). In control hypertensive animals, the wt of the clipped kidney did not decrease whereas significant hypertrophy was present in the unclipped kidney. Tripletherapy did not alter this relationship, whereas converting enzyme inhibition decreased kidney wt in the clipped kidney and increased further the hypertrophy of the contralateral unclipped kidney. A histological examination revealed that hypertensive microangiopathy was a predominant feature in the unclipped kidney of the untreated hypertensive group and of the group treated with tripletherapy, these lesions were completely absent in the CEI treated group. In the CEI treated group, however, ischemic lesions during this treatment were found to be decreased in the contralateral unclipped kidney and increased in the clipped kidney by comparison with untreated hypertensive rats. These renal lesions observed in the clipped kidney were most likely related to the normalization of blood pressure or to a disturbance of intrarenal mechanisms normally mediated by the renin-angiotensin system during stenosis of a renal artery.
为了研究抗高血压治疗对单夹双肾肾血管性高血压大鼠激素和肾脏参数的影响,我们在该大鼠实验模型中比较了转换酶抑制(CEI)与三联疗法(可乐定、双肼屈嗪和呋塞米)的效果。治疗期在夹闭后四周开始,并持续五周。血浆中肾素增加,肾素底物与血浆肾素呈负相关。高血压与血浆和肾脏中肾素 - 血管紧张素系统的激活有关。通过两种方法评估夹闭肾中肾素 - 血管紧张素系统的激活程度及其在未夹闭肾中的抑制程度,即肾肾素含量和通过免疫荧光肾素对肾小球旁器增生进行半定量。这两种方法具有相关性。在治疗期间,CEI治疗组(HT1)的平均收缩压为144±13 mmHg,与假手术组(139±4 mmHg;C2)的值无显著差异。然而,三联疗法治疗组(HT2)的血压仅降至173±18 mmHg。在对照高血压动物中,夹闭肾的重量没有减少,而未夹闭肾中存在明显肥大。三联疗法未改变这种关系,而转换酶抑制降低了夹闭肾的肾脏重量,并进一步增加了对侧未夹闭肾的肥大。组织学检查显示,高血压微血管病变是未治疗高血压组和三联疗法治疗组未夹闭肾的主要特征,而在CEI治疗组中这些病变完全不存在。然而,与未治疗的高血压大鼠相比,在CEI治疗组中,治疗期间对侧未夹闭肾的缺血性病变减少,夹闭肾的缺血性病变增加。在夹闭肾中观察到的这些肾脏病变很可能与血压正常化或肾动脉狭窄期间通常由肾素 - 血管紧张素系统介导的肾内机制紊乱有关。